Stoke Therapeutics Inc (STOK)
14.08
-0.34
(-2.32%)
USD |
NASDAQ |
May 28, 16:00
14.07
0.00 (0.00%)
After-Hours: 20:00
Stoke Therapeutics Cash from Operations (Quarterly): -24.57M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -24.57M |
| December 31, 2023 | -20.65M |
| September 30, 2023 | -17.26M |
| June 30, 2023 | -21.80M |
| March 31, 2023 | -21.36M |
| December 31, 2022 | -22.37M |
| September 30, 2022 | -22.06M |
| June 30, 2022 | -19.93M |
| March 31, 2022 | 32.49M |
| December 31, 2021 | -16.26M |
| September 30, 2021 | -14.68M |
| June 30, 2021 | -15.83M |
| March 31, 2021 | -20.14M |
| Date | Value |
|---|---|
| December 31, 2020 | -10.93M |
| September 30, 2020 | -10.87M |
| June 30, 2020 | -9.646M |
| March 31, 2020 | -10.77M |
| December 31, 2019 | -10.20M |
| September 30, 2019 | -8.048M |
| June 30, 2019 | -6.274M |
| March 31, 2019 | -6.532M |
| December 31, 2018 | -3.515M |
| September 30, 2018 | -3.041M |
| June 30, 2018 | -2.419M |
| March 31, 2018 | -1.989M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-24.57M
Minimum
Mar 2024
32.49M
Maximum
Mar 2022
-13.56M
Average
-16.04M
Median
Cash from Operations (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -2.003M |
| iBio Inc | -3.654M |
| Actinium Pharmaceuticals Inc | -7.374M |
| Lixte Biotechnology Holdings Inc | -0.7892M |
| Fate Therapeutics Inc | -33.35M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 9.988M |
| Cash from Financing (Quarterly) | 1.717M |
| Free Cash Flow | -85.74M |
| Free Cash Flow Per Share (Quarterly) | -0.5315 |
| Free Cash Flow to Equity (Quarterly) | -24.58M |
| Free Cash Flow Yield | -13.56% |